CBR is uniquely positioned to take on the challenge of tackling this impending healthcare and socioeconomic crisis.”
The Pratiksha Trust signed an MoU with the Indian Institute of Science (IISC) and Centre for Brain Research (CBR), an autonomous centre of IISC, to accelerate breakthrough discoveries and translational research on neurodegenerative diseases.
Under this MoU, the charitable trust, founded by Infosys co-founder Kris Gopalkrishnan, has agreed to provide support to CBR in perpetuity with an initial outlay to the tune of Rs 450.27 crore over the next 10 years, for research, innovation and translation.
IISC Director Prof G Rangarajan said, “India’s elderly population is expected to grow rapidly to a staggering 32 crore by 2050, leading to a corresponding increase in the burden of dementia and other age-related neurodegenerative diseases. CBR is uniquely positioned to take on the challenge of tackling this impending healthcare and socioeconomic crisis.”
Gopalakrishnan said, “The human brain is one of the world’s biggest mysteries, which is yet to be fully understood. By funding this centre, we are working towards creating and sustaining a globally recognised, state-of-the-art research and innovation hub that will be at the cutting edge of research on the human brain.”
CBR has already been pursuing research in this area and this MoU will help scale up the research and activities at the centre. It is also a part of nation-wide initiative involving 20 institutions called “Genome-India” (supported by the Department of Biotechnology, Government of India), which aims to discover India-specific genetic basis for diseases through whole genome sequencing of 10,000 samples collected from across the country.
newindianexpress.com